Dihydroergocristine mesylate is a methanesulfonic acid salt of dihydroergocristine, an ergot alkaloid derivative. It has been employed as an active pharmaceutical ingredient for symptomatic management of mental decline associated with cerebrovascular insufficiency and in peripheral vascular disease.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 24730-10-7
Dihydroergotamine mesylate
active pharmaceutical ingredient
Dihydro-alpha-ergocryptine mesylate
active pharmaceutical ingredient
(S,E)-N-(4-((4-CHLORO-3-FLUOROPHENYL)AMINO)-7-((TETRAHYDROFURAN-3-YL)OXY)QUINAZOLIN-6-YL)-4-(DIMETHYLAMINO)BUT-2-ENAMIDE
active pharmaceutical ingredient
(-)-Epiafzelechin
active pharmaceutical ingredient (API) standard
Prasteronyl Abiraterone
active pharmaceutical ingredient
(3alpha)-3-Acetate-17-(3-pyridinyl)-androsta-5,16-dien-3-ol
Abiraterone acetate impurity
Acidihydroergocristine
pharmaceutical reference standard
(6aR,9R,10aR)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;methanesulfonic acid
SPXACGZWWVIDGR-SPZWACKZSA-N
CC(C)[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C.CS(=O)(=O)O